918. Identification of novel druggable host targets for Middle East respiratory syndrome coronavirus using a quantitative phosphoproteomics approach

por Chan, Jasper F W, Hu, Bingjie, Chik, Kenn K H, Yuan, Shuofeng, Chu, Hin
Publicado 2023

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

por Yuan, Shuofeng, Chan, Jasper F.W., Chik, Kenn K.H., Chan, Chris C.Y., Tsang, Jessica O.L., Liang, Ronghui, Cao, Jianli, Tang, Kaiming, Chen, Lin-Lei, Wen, Kun, Cai, Jian-Piao, Ye, Zi-Wei, Lu, Gang, Chu, Hin, Jin, Dong-Yan, Yuen, Kwok-Yung
Publicado 2020

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

por Iketani, Sho, Liu, Lihong, Guo, Yicheng, Liu, Liyuan, Chan, Jasper F.-W., Huang, Yiming, Wang, Maple, Luo, Yang, Yu, Jian, Chu, Hin, Chik, Kenn K.-H., Yuen, Terrence T.-T., Yin, Michael T., Sobieszczyk, Magdalena E., Huang, Yaoxing, Yuen, Kwok-Yung, Wang, Harris H., Sheng, Zizhang, Ho, David D.
Publicado 2022